P20 A comparison of the cardiovascular effects of empagliflozin and liraglutide: a systematic review and meta-analysis
Abstract
Background With the recent publication of the EMPA-REG Outcome and LEADER trials, we now have two diabetes drugs which improve cardiovascular outcome. The aim of this study was to conduct a meta-analysis of the CV effects of empagliflozin and liraglutide to provide a better understanding of the mechanisms that may have led to these positive results. Methods A systematic search was carried out. RCT of empagliflozin and liraglutide against both placebo and active comparator were included. In total 52 studies were included, involving 33,500 patients in total (empagliflozin: 14,415 patients; liraglutide: 19,085 patients). Various CV parameters were compared. Meta-analysis was conducted using REVMAN 5.3. Results Both empagliflozin and liraglutide caused a significant reduction in weight and systolic blood pressure. Empagliflozin also caused a significant drop in BP. There was a significant increase in heart rate with liraglutide. Liraglutide caused a significant decrease in lipid parameters whereas empagliflozin caused a significant increase in lipids. Conclusions The results of this meta-analysis might provide some explanation for the cardiovascular effects seen in LEADER and EMPA-REG. Empagliflozin’s reduction in weight and BP may partially explain its beneficial effects on heart failure, while the increase in cholesterol may also explain why there was no significant difference in MI and a trend to increased stroke risk. The reduction in cholesterol and blood pressure caused by…
How strong is the evidence?
Evidence Hub reads this as a meta-analysis. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid. Reported size: 33,500 participants or records.
Read the paper
Related studies
- Risk Factors for Coronavirus Disease 2019 (COVID-19) Death in a Population Cohort Study from the Western Cape Province, South Africa
- Global and regional estimates of genital human papillomavirus prevalence among men: a systematic review and meta-analysis
- A methodology for assessing deployment trauma and its consequences in OEF/OIF/OND veterans: The TRACTS longitudinal prospective cohort study
- Post‑COVID‑19 Syndrome in Outpatients: a Cohort Study
- Factors Influencing Primary and Secondary Implant Stability—A Retrospective Cohort Study with 582 Implants in 272 Patients
- Electroacupuncture for Painful Diabetic Peripheral Neuropathy: A Multicenter, Randomized, Assessor-Blinded, Controlled Trial
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.